YANGI AVLOD ANTIBIOTIKLARI VA ANTIBIOTIKKA CHIDAMLILIK MUAMMOSI
Keywords:
antibiotikga chidamlilik, AMR, yangi avlod antibiotiklar, tibbiy kimyo, gepotidacin, zosurabalpin, Gram-manfiy bakteriyalar.Abstract
Antibiotikka chidamlilik (AMR — Antimicrobial Resistance) global sog‘liqni saqlashning eng jiddiy tahdidlaridan biri hisoblanadi. Jahon sog‘liqni saqlash tashkiloti (JSST) ma’lumotlariga ko‘ra, 2023 yilda har oltinchi laboratoriyada tasdiqlangan bakterial infeksiya antibiotiklarga chidamli bo‘lgan. Ushbu maqolada AMR ning hozirgi holati, mexanizmlari, yangi avlod antibiotiklarning tibbiy kimyoviy asoslari va ularning muammoni yumshatishdagi roli adabiyotlar tahlili asosida batafsil yoritilgan. Natijalar shuni ko‘rsatadiki, gepotidacin, zosurabalpin kabi yangi mexanizmli antibiotiklar umidvor bo‘lsa-da, pipeline tor va kompleks yondashuv talab etiladi.
References
World Health Organization. Global antibiotic resistance surveillance report 2025: WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS). Geneva: World Health Organization, 2025. 138 s.
Naghavi M. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 // The Lancet. 2024. Vol. 404, № 10459. P. 1199–1226. DOI: 10.1016/S0140-6736(24)01867-1.
Zampaloni C. A novel antibiotic class targeting the lipopolysaccharide transporter // Nature. 2024. Vol. 625. P. 566–574. DOI: 10.1038/s41586-023-06873-0.
Glaxo S.K. Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urinary tract infections. London, 2025. (Press-reliz).
Jesudason T. et al. Antibacterial agents in preclinical and clinical development // The Lancet Microbe. 2024. DOI: 10.1016/S2666-5247(24)00215-5.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo